To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
USA119th CongressHR-9077| House
| Updated: 5/29/2026
Hillary J. Scholten
Democratic Representative
Michigan
Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
USA119th CongressHR-9077| House
| Updated: 5/29/2026
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Hillary J. Scholten
Democratic Representative
Michigan
Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted